As Director and CEO of the Cancer Center, Cheryl Willman, MD, is responsible for all cancer research and cancer clinical programs institution-wide at UNM. She is responsible for establishing the overall vision and development of strategic plans. Working with her Associate Directors and Cancer Center Administrative Staff, she is responsible for the execution of the Ciinical Programs, Research Programs, Shared Resources, and Support Elements. She interfaces with the UNM Leadership and with External and Internal Advisory Boards for assistance with planning and evaluation She is particularly focused on integration of basic, population-based, translational and clinical cancer research activities to build outstanding multidisciplinary, interdisciplinary, and transdisciplinary programs. As Deputy Director of Clinical Affairs and Translational Research, Robert Hromas, MD, oversees clinical care, clinical and translation research, and professional education efforts of the Cancer Center. In his oversight role of clinical oncology research, he supervises the Clinical Trials and Informatics Shared Resource led Dr. Jones M.D. and Ms. Stewart, the Protocol Review and Monitoring System led by Drs. Royce and Muller, and the Protocol-Specific Research Support led by Dr. Verschraegen. In patient care services, he works with Medical Executive Director Dr. Lauer and with Dr. Rabinowitz, the Clinical Director. In his oversight role of professional education, he supervises the Hematology-Oncology Fellowship Program led by Dr. Rabinowitz, and the medical student and resident Hematology-Oncology training led by Dr. Libby. As Associate Director of Basic Research, Larry Sklar, PhD, co-ordinates the Research Programs, Shared Resources, Planning and Evaluation, Developmental Funds and Cancer Center Research Administration (CCRA). CCRA is led by COO, Ms. Rae Ann Paden who co-ordinates the activities of CFO, Mr. Bradley Mucek and senior accountant Ronda Johnson, the research program office led Ms. Sheryl Curtin, and staff, as well as the shared resource team of Mrs. Kimberly Golden and staff. Paden also coordinates the Cancer Center seminar program and runs internal grant competitions.. As Associate Director for Shared Resources, Scott Ness, PhD, oversee shared resource operations. As Associate Director of Partnerships and Professional Development, Janet Oliver, PhD, works closely with Dr. Wiiiman and Dr. Sklar to build partnerships with scientists in the UNM Colleges of Arts and Sciences and Engineering and at neighboring institutions, including Sandia National Laboratories, and Los Alamos National Laboratories. She assures that junior faculty with Cancer Center and ACS pilot awards are receiving adequate mentoring, release time and resources for research. As Associate Director for Population Sciences, Marianne Berwick, PhD, is responsible for developing the programs in Population Science: Cancer Epidemiology, Cancer Prevention and Control, Community Intervention, Cancer Screening, and Outreach to Native Americans and Hispanics. Reporting to Dr. Berwick are Dr. Richard Hoffman, Associate Director for Cancer Prevention and Control, Michelle Suina, Program Manager for Native American Outreach and Maria Otero, Program Manager for Hispanic Outreach, and Robyn Viera, Program Manager for Community Advisory Groups. Dr. Berwick is responsible for recruiting new faculty to this program and creating liaisons with community leaders and providers. As Consultant for Outreach and Community Affairs, Michael Trujillo, MD, providing expertise and insight into Cancer Center interactions with underserved Hispanic and Native American populations in New Mexico.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of New Mexico Health Sciences Center
United States
Zip Code
Steffen, Laurie E; Du, Ruofei; Gammon, Amanda et al. (2017) Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode. Cancer Epidemiol Biomarkers Prev 26:1772-1780
Cleyrat, C├ędric; Girard, Romain; Choi, Eun H et al. (2017) Gene editing rescue of a novel MPL mutant associated with congenital amegakaryocytic thrombocytopenia. Blood Adv 1:1815-1826
Oruganti, S R; Torres, D J; Krebsbach, S et al. (2017) CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS. Leukemia 31:255-258
Belinsky, Steven A; Leng, Shuguang; Wu, Guodong et al. (2017) Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence. Cancer Prev Res (Phila) 10:635-640
Hill, Deirdre A; Barry, Marc; Wiggins, Charles et al. (2017) Estrogen receptor quantitative measures and breast cancer survival. Breast Cancer Res Treat 166:855-864
Meyer, Matthias R; Rosemann, Thomas; Barton, Matthias et al. (2017) GPER Mediates Functional Endothelial Aging in Renal Arteries. Pharmacology 100:188-193
Flores, Kristina G; Steffen, Laurie E; McLouth, Christopher J et al. (2017) Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. J Genet Couns 26:480-490
Wang, Jing; Samuels, David C; Zhao, Shilin et al. (2017) Current Research on Non-Coding Ribonucleic Acid (RNA). Genes (Basel) 8:
Leng, Shuguang; Wu, Guodong; Klinge, Donna M et al. (2017) Gene methylation biomarkers in sputum as a classifier for lung cancer risk. Oncotarget 8:63978-63985
Kimura, Tomonori; Jia, Jingyue; Kumar, Suresh et al. (2017) Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J 36:42-60

Showing the most recent 10 out of 272 publications